ANTX biotech catalysts & pipeline

AN2 THERAPEUTICS INC · Data as of 2026-10-25

Upcoming catalysts

epetraborole — Clinical data readout

2027

The Company anticipates releasing Part 1 data periodically throughout 2027.

Source filing

epetraborole — Topline data

late 2027

The Company anticipates reporting topline results in late 2027, subject to enrollment progress.

Source filing

epetraborole — Conference presentation

Oct 29

Poster Session Details Title: Phase 2 Study of Oral Epetraborole for Treatment of Phlebotomy-Dependent PV Date: Thursday, October 29, 2026 Time: 5:45-7:15pm ET Poster number: 148

Source filing

Explore the free biotech catalyst calendar